Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03351140 · ClinicalTrials.gov registry record
Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 1
- Enrollment target
NCT03351140 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 1 participants.
The verdict
NCT03351140 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The objective of this study is to conduct in-person qualitative interviews of subjects who have different tumor types to identify and assess relevant PROMIS physical function items that can be utilized in future studies. Health Research Associates (HRA) will conduct qualitative interviews in subjects with a variety of cancer types. PROMIS is a set of self-report measurement tools, developed by the United States (US) National Institutes for Health (NIH). The most recent version of PROMIS Physical Function Item Bank contains 165 items assessing a range of abilities and its subset, a 45-item PROMIS Function Cancer Item Bank which contains questions relevant to subjects with cancer. Approximately 150 subjects with five tumor types will be recruited. HRA will conduct the interviews that will be audio-recorded for transcription and analysis. Five tumor types that will be focused on are Breast, Prostate, Non-Small-Cell Lung Cancer (NSCLC), Multiple Myeloma, and Diffuse Large B-Cell (DLBCL) or Follicular Lymphoma. Interviews will be conducted in English language in private areas within clinic site or rented meeting facilities and will last approximately for 60-90 minutes.
Interventions
- OTHER Qualitative Interviews
- OTHER PROMIS Physical Function Items
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-12-20 |
| Est. Completion | 2020-05-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03351140
The ClinicalTrials.gov registry entry for NCT03351140 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Qualitative Interviews is the first listed.
NCT03351140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03351140 about?
NCT03351140 is a clinical study titled "Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function". The objective of this study is to conduct in-person qualitative interviews of subjects who have different tumor types to identify and assess relevant PROMIS physical function items that can be utilized in future studies. Health Research Associates (HRA) will conduct qualitative interviews in subject...
What is the current status of trial NCT03351140?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2017-12-20. Estimated completion is 2020-05-08.
What interventions are being tested in trial NCT03351140?
The interventions under investigation include: Qualitative Interviews (OTHER), PROMIS Physical Function Items (OTHER).
Who is sponsoring clinical trial NCT03351140?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.